Skip to content
TVTX·Nasdaq·US

Travere Therapeutics

Travere Therapeutics is a biopharmaceutical company headquartered in San Diego, California, focused on identifying, developing and delivering therapies to people living with rare kidney and metabolic diseases. Its approach centers on advancing an innovative pipeline with multiple late-stage clinical programs targeting rare diseases with significant unmet medical needs.

Source: SEC 10-K Feb 19, 2026

Thematic Position

TVTX

Relationship Groups

Licensing2
Competitors16

Relationship details are part of the Pro plan.

Recent Discoveries

Recent discoveries are part of the Pro plan.

Ended Relationships

3 ended relationships · Ended relationships are part of the Pro plan.

Management Perspective on Regulatory & Geopolitical Developments

data transaction restrictionnational security review
DOJ rule restricts data transactions with China, Russia, Iran and covered persons
SEC 10-QAug 4, 2026

The full regulatory passage is part of the Pro plan.

22 more · Regulatory and geopolitical insights are part of the Pro plan.